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Abstract
Background: Detailed human studies of the mechanisms and development of shunt infection in
real time are not possible, and we have developed a canine hydrocephalus model to overcome this.
The intention of this pilot study was to show that the canine hydrocephalus model could be
shunted using conventional "human" shunts, and that a shunt infection could be established so that
further studies could then be planned.
Methods:  Hydrocephalus was induced in seven dogs (Canis familiaris) by fourth ventricle
obstruction. Four weeks later they were shunted using a Hakim Precision valve. Four of the dogs
received shunts whose ventricular catheter had been inoculated with Staphylococcus epidermidis, and
three were uninoculated controls. Four weeks after shunting the dogs were sacrificed and necropsy
was performed. Removed shunts and tissue samples were examined microbiologically and isolates
were subjected to detailed identification and genomic comparison.
Results: All the dogs remained well after shunting. Examination of removed shunt components
revealed S. epidermidis in the brain and throughout the shunt system in the four inoculated animals,
but in two of these Staphylococcus intermedius was also found. S. intermedius was also isolated from
all three "negative" controls. There were slight differences between S. intermedius strains suggesting
endogenous infection rather than cross- infection from a point source.
Conclusion: Shunt infection was established in the canine model, and had the experiment been
extended beyond four weeks the typical microbiological, pathological and clinical features might
have appeared. The occurrence of unplanned shunt infections in control animals due to canine
normal skin flora reflects human clinical experience and underlines the usual source of bacteria
causing shunt infection.
Background
The introduction of cerebrospinal fluid (CSF) shunts rev-
olutionized the treatment of hydrocephalus and greatly
decreased mortality rate. However, over subsequent dec-
ades, difficulties in shunt maintenance and problems
resulting from infection or occlusion have persisted [1].
Today, shunt failure rates range from 25% to 40% in the
first few months after surgery [2,3]. After this critical
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period, the risk remains at 4% – 5%. As a result, some
patients may have numerous shunt revisions during their
lifetime, representing a major medical risk. Infections
have been a leading cause of shunt failure with infection
rates ranging from 1% to 30% [4-8]. Overall, the interna-
tional reported incidence is around 10% [9]. Gram posi-
tive bacteria are most commonly implicated, and
approximately 80% are caused by staphylococci, most of
these being Staphylococcus epidermidis [9,10]. These organ-
isms originate on the patient's skin and mucous mem-
branes and investigational and clinical evidence indicates
that the inoculation of the shunt system occurs at the time
of operation [11]. The severity of a shunt infection may
vary from a sub-clinical colonization of the shunt inner
lumen surface to fulminating ventriculitis, meningitis, or
encephalitis which can be neurologically catastrophic,
although the picture with S. epidermidis infections is typi-
cally low-grade. A shunt-related infection of the central
nervous system (CNS) is of particular concern because of
the threat to cerebral functions. Treatment may be pro-
longed and relapses may occur, complicating control of
intracranial pressure and giving rise to life-threatening
risks such as cognitive and neurological deficits
[3,6,12,13].
Although many studies have investigated the rate, aetiol-
ogy and epidemiology of shunt infections, preventive
measures are difficult to study, and their pathophysiology
is largely unknown due to the difficulties inherent in
human studies. Animal models of infection in other
implantable devices have not hitherto been suitable for
these purposes. We have developed a canine model of
chronic obstructive hydrocephalus [14] which produces a
gradual, well – tolerated increase in ventricular size,
resulting in transient and subtle clinical effects. Unlike
previous models, there is no focal compression or general
inflammation which may confound analysis [15,16].
Because of the size of the animals this model allows actual
shunting procedures to be carried out using shunts
designed for human use, and clinically relevant measure-
ments to be made for the purposes of diagnosis, treatment
and research. This paper, therefore, describes and charac-
terises an animal model able to address these issues, and
reports its use in a pilot study of chronic low-grade shunt
infection.
Methods
Animals and induction of hydrocephalus
Seven young adult (8–9 months) male purpose – bred
mongrel dogs (Canis familiaris) weighing 25–30 kg were
used for this study. Animals were obtained from licensed
suppliers and quarantined for a minimum of seven days
before entering the study. They were maintained in the
Cleveland Clinic's fully accredited Animal Care Facility
and their maintenance and all experimental procedures
were conducted in accordance with the National Institutes
of Health (NIH) and The Cleveland Clinic Foundation
Animal Research Committee (ARC) guidelines for the use
and care of laboratory animals. Each experiment began
with the induction of obstructive hydrocephalus (time
zero), the details of which have been previously described
[14,17]. General endotracheal anaesthesia by 1% isoflu-
rane gas inhalation was used for all surgeries. Briefly, a
midline suboccipital craniotomy was performed enabling
the skin and muscles to be retracted and the dura opened
along the midline. Animals were given gentamicin (40 mg
i.v.) and cefazolin (1 g i.v.) prophylactically. The cerebel-
lar vermis and tonsil were exposed and retracted upward,
to allow a flexible silicone catheter (~1.5 mm diameter)
connected to a 1 mL syringe to be inserted through the
foramen of Magendie into the fourth ventricle.
Cyanoacrylic gel (0.4 – 0.6 mL) was injected into the
fourth ventricle to obstruct the normal flow of CSF. The
catheter was left in position after being cut at the level of
the foramen of Magendie, and the dura was closed with 5-
0 Ethibond. After muscle, fascia, and skin were closed in
layers, each animal was admitted to intensive care for
recovery (24–72 hours). All the animals received Tylenol
for pain. Severe pain was controlled with torbutrol (0.4
mg/kg, i.m. b.i.d. for 5 days). In the event that an animal
did not eat and was losing weight, subcutaneous dextrose
feeding was administered. In addition, if any animal pre-
sented with symptoms of acute hydrocephalus, medical
treatment for increased intracranial pressure (ICP) includ-
ing mannitol (0.25–1.0 g/kg), diamox (125 mg), and dec-
adron (4–6 mg) was administered.
Shunt insertion and inoculation
Approximately four weeks after induction, the hydro-
cephalic animals underwent a standard shunt implanta-
tion surgery. The preoperative method of sedation and
positioning with the stereotaxic head frame was the same
as described previously [14,17]. The animals did not
receive any antibiotic prophylaxis before or after surgery
for implantation of the shunt system and inoculation.
Ventriculomegaly was confirmed by MRI [14]. Images
were obtained at baseline and at time of sacrifice, and
were compared using planimetric measures (i.e. Evans
ratio). Overall, all animals induced with chronic hydro-
cephalus had an Evans ratio >0.3. However, the degree or
severity of hydrocephalus was not relevant for this study,
and all animals were surgically implanted with a ventricu-
loperitoneal (VP) shunt regardless of the degree of ven-
triculomegaly. A frontal burr hole craniotomy was
performed and a standard silicone shunt with a one-way
pressure valve was used for the VP shunt procedure
(HAKIM Precision Valve Standard without prechamber,
opening pressure: 10 ± 10 mm H2O, Codman and Shurtl-
eff Inc, Raynham, MA, USA). Prior to placement, the ven-
tricular catheter in four of the animals was inoculatedCerebrospinal Fluid Research 2008, 5:17 http://www.cerebrospinalfluidresearch.com/content/5/1/17
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with S. epidermidis sensu stricto, F22, a clinical isolate from
a proven VP shunt infection. A suspension of the bacteria
was prepared in 2 mL of 0.85% saline to give an absorb-
ance at a wavelength of 490 nm of 0.6 equivalent to a bac-
terial count of 1.0 × 108 colony forming units (cfu) per mL
and the catheter was filled with this suspension. The
remaining three animals were not inoculated. Post-opera-
tive monitoring and care was similar to that described for
the post-induction recovery period except that no antibi-
otics were given. The animals were checked daily and data
on temperature, heart rate, food and water intake, and
incision site were obtained. The animals were weighed
weekly, and closely monitored for clinical signs of infec-
tion for the four weeks following the shunt inoculation
and implantation procedure. These signs included sys-
temic variables such as sepsis and a persistent fever greater
than 39.1°C, neurological variables such as lethargy,
coma, seizures, and focal deficits, and local variables such
as swelling, redness, soreness, and discharge. If no signs of
infection occurred during the 4 weeks of observation, the
animals were anaesthetized and a dissection was per-
formed under aseptic conditions.
Shunt removal and sampling
The distal end of the VP shunt was carefully exposed by
gross dissection and ligated with silk sutures at the ven-
tricular catheter, proximal and distal to the valve, and at
the most distal end of the shunt tubing. Biopsies of the
brain parenchyma and meninges adjacent to the ventricu-
lar catheter track were obtained via a 2 cm bilateral cranial
burr hole. A biopsy of the peripheral tissue adjacent to the
valve was obtained and the valve removed. The distal
catheter tip was cut and removed along with the remain-
ing peritoneal shunt tubing. The three tissue samples
(brain parenchyma, tissue adjacent to the valve and peri-
toneal tissue adjacent to the distal catheter tip), catheter
tips (proximal and distal ends), ligated shunt, and the CSF
samples (Fig 1) were sent for microbiological analysis
(Cleveland Clinic, G.H., M.T.). CSF samples were
obtained by lumbar puncture (LP). Each dog was then sac-
rificed with KCl while under anaesthesia and perfused
intravascularly with 4 L of 4% paraformaldehyde fixative
(Prills, 95%, Aldrich Chemical Company, Ind., USA) in
0.1 M PBS, via the internal carotid artery. The brain was
removed from the skull and stored in cryostorage solution
(30% sucrose) until further processing.
Diagram of sample sites at necropsy Figure 1
Diagram of sample sites at necropsy. A: proximal catheter; B: parenchymal brain tissue adjacent to the catheter; C: distal 
catheter; D: distal catheter tip in the peritoneal cavity; E: tissue adjacent to distal catheter tip; F: tissue along the catheter track; 
and G: cerebrospinal fluid from the lumbar subarachnoid space.Cerebrospinal Fluid Research 2008, 5:17 http://www.cerebrospinalfluidresearch.com/content/5/1/17
Page 4 of 7
(page number not for citation purposes)
Microbiology
The tissue samples, catheter tips and lumbar CSF samples
underwent routine microbiological processing. The
ligated shunt tubing was sonicated for one minute, and
fluid withdrawn from the lumen for culture. After incuba-
tion overnight in CO2 at 35°C, bacterial growth and iden-
tification for all samples were determined. The isolates
were then sent to the University of Nottingham (R.B.) for
further examination. After confirmation of identity using
basic tests, each isolate was examined by APIStaph
(bioMérieux, Marcy L'Etoile, France), numerical antibio-
gram [18] and pulse field gel electrophoresis (PFGE)
(ChefII -DRII, Bio-Rad Laboratories Ltd, Hemel Hemp-
stead, UK).
Pathology
Each brain and its corresponding meninges was examined
for gross signs of encephalitis, meningitis, and ventriculi-
tis (GP). Tissue from the right cerebral hemisphere, which
included the ventricular catheter track from each animal
was embedded in paraffin wax, sectioned at 8 μm, and
stained with haematoxylin and eosin, and the Brown-
Brenn tissue Gram stain.
Results
Induction of hydrocephalus
All seven animals that underwent the induction of chronic
hydrocephalus procedure recovered from surgery. One
animal developed symptoms of acute hydrocephalus and
required two days of observation in the Critical Care Unit
and treatment of raised ICP before resolution. In the
remaining animals, vital signs monitored (weight, tem-
perature, heart rate, and food and water intake) during the
three to four-week period following the induction surgery
remained in the normal range. At the time of sacrifice,
Evans ratio of all animals was >0.3 confirming ventricu-
lomegaly. There was no incidence of mortality or morbid-
ity in any animal for either the experimental or control
groups. Most hydrocephalic animals exhibited signs of
lethargy, motor weakness, anorexia, and ataxia in the first
seven days immediately following surgery. Vomiting
often accompanied neurological signs (i.e., pupillary dila-
tion and reflex impairment) reflecting increased ICP.
These neurological signs were observed to be transient
and resolved within the first one to two days. No animal
was observed to be febrile. Autopsy performed in each
animal revealed no evidence of intracerebral or intraven-
tricular bleeding, which corroborated with MRI data. In
addition, the surgical incision site in all animals healed
well and did not show any signs of infection.
Shunting and inoculation
Six of the seven dogs lost weight during the first week fol-
lowing induction of hydrocephalus. The one animal that
did not lose weight following surgery and one other ani-
mal whose weight returned to normal following recovery
from induction, had shown a weight loss two weeks prior
to the shunt implantation surgery. Food intake decreased
by almost 50% eight days prior to the shunting procedure.
In the four-week period following shunting all animals
showed a steady weight gain for the remainder of the
study. The animals recovered from the shunt-inoculation
procedure very quickly. They had normal consumption of
food and fluid the first day post-operatively. Gait and vital
signs were normal for the four-week period following the
inoculation-shunt procedure. None was febrile and there
were no signs of infection of the abdominal or head
wounds.
Observations at Dissection
At dissection, the animals were deeply anaesthetized,
facilitating close examination of the wounds. In five of the
seven animals, upon opening the healed sutured skin on
the head, fluid collection was observed. In one animal this
fluid was thick and slightly discoloured and followed the
shunt catheter distally to the valve (neck region). On
removal of the ventricular catheters, a plug appeared to
block the end of the catheter in five animals. In addition,
there was protein matter (non-brain) infiltrating some of
the valve systems. No visual signs of infection were
observed at the abdominal insertion incision. At autopsy
no peritoneal cysts or other abnormalities were observed.
Microbiology Results
These are summarized in Table 1. The LP CSF samples (G)
showed only a few leukocytes and all were culture – neg-
ative. The four animals inoculated with S. epidermidis grew
this organism from most of the collected samples (dogs 1,
3, 4, 5,). In two of these four "S. epi" animals, a second
bacterium was also cultured. This was identified
(APIStaph) as Staphylococcus intermedius.  S. intermedius
was grown in broth culture only from the brain tissue and
proximal catheter samples of one animal and from the
peritoneal tissue sample from the second animal. In the
Table 1: Culture results from various sites at necropsy.
Animal A B C D E F G Gross signs
1 Si Si Se Se NG NG NG +
2 S iS iS iS i S i S i N G +
3 Se Se Se Se Si NG ND -
4 Se Se Se Se Se NG ND +
5 Se Se Se Se Se Se NG +
6 S iS iS iS i S i S i N G +
7 S iS iS iS i S i N GN G -
Sampling sites A-G are shown in Figure 1. Si: Staphylococcus 
intermedius; Se: Staphylococcus epidermidis (the inoculated strain). NG: 
no growth; ND: not done. Gross signs of infection were noted as 
present (+) or absent (-) at necropsy. The shunts of dogs 1, 3, 4 & 5 
(bold type) were inoculated with S epidermidis, and dogs 2,6 & 7 
remained uninoculated.Cerebrospinal Fluid Research 2008, 5:17 http://www.cerebrospinalfluidresearch.com/content/5/1/17
Page 5 of 7
(page number not for citation purposes)
remaining three uninoculated control animals (dogs 2, 6,
7), all samples were positive for S. intermedius. The S. inter-
medius isolates were compared by APIStaph, numerical
antibiogram and PFGE (Fig 2). The results of these were
collated and are shown in Table 2. The PFGE, biochemical
and antibiogram profiles for F 1568 and F1569 (dog 1,
inside and outside the tubing) were identical; F 1567, F
1570, F1571 and F 1572 showed slight differences in one
or other profiles. Isolates from dogs 2, 3, 6 and 7 were
therefore similar to each other but differed from those
from dog 1.
Pathology Results
Histopathological examination revealed no sign of ven-
triculitis or inflammation. There was minimal amount of
gliosis and scarring in the brain tissue surrounding the
catheter track similar to and consistent with previous
reports and found after insertion of ventricular catheters
in the absence of infection. Also, there was no evidence of
bacterial invasion on Gram stain.
Discussion
One of the more striking findings from this study was the
survival and overall health of each animal, with weight
gain and no signs of systemic infection after shunting. The
wounds healed well and there was no general spread of
bacteria within the ventricular system and no classic signs
of inflammation in the brain. The features of overt shunt
infection include fever, with in some cases inflammation
over the catheter track and possible wound breakdown.
Distal obstruction of the peritoneal catheter, with conse-
quent signs of raised intracranial pressure, would be
expected. None of these was seen, and benign pathophys-
iology and lack of bacterial spread may be surprising in
view of the large inoculation with S. epidermidis. It could
be explained in part by the termination of the experiment
at 4 weeks; these low-grade staphylococcal infections
often have a longer latency and are more indolent and dif-
ficult to diagnose. They cause little or no direct injury, but
if untreated they will eventually usually cause distal cath-
eter obstruction due to adhesions or pseudocyst forma-
tion [19,20]. However, there is another possible
explanation: S. epidermidis infections are a challenge to
diagnose and treat, in part because of the ability of most
strains to grow inside shunts as biofilms [21,22]. Bacteria
in biofilms downregulate their synthesis of target sites for
antibiotics, thus becoming insusceptible to antibiotic
therapy [23]. The biofilm mode may be another explana-
tion for the finding of uniformly positive catheter lumen
cultures but no evidence of bacterial spread, invasion, or
inflammation in the periventricular brain and ependyma.
The negative lumbar CSF cultures as well as the benign
central nervous system pathology may indicate the inabil-
ity of this bacterium to migrate rapidly from the adherent
biofilms into the surrounding tissues, though the lumbar
CSF would not be likely to show signs of infection in view
of the obstructive hydrocephalus. Indeed, the human clin-
ical features of S. epidermidis VP shunt infection, especially
at four weeks post surgery, show a similar limited
response. While there was no evidence of inflammation
using standard histological techniques, other markers of
inflammation and infection, such as microglial prolifera-
tion and changes in cytokine levels in the brain and/or
CSF might have been informative. Also, more pathologi-
cal abnormalities might become apparent in future stud-
ies when the infections are allowed to run for several
months before sacrifice. This is suggested by the finding of
subgaleal fluid collections in five of the animals on dissec-
tion.
Using the model a 100% infection rate (four out of four
animals inoculated with S. epidermidis) was achieved and
verified by gross examination and culture of hardware and
tissue. In addition, the important role of skin flora in
seeding of a shunt system during insertion was demon-
strated fortuitously by the high rate of S. intermedius isola-
tion, the three dogs that were not inoculated with S.
epidermidis all contracting shunt infections due to S. inter-
medius. The evidence of infection decreased with samples
taken downstream of the catheter in the peritoneal cavity,
and none was found in the lumbar fluid.
Table 2: Comparison of the Staphylococcus intermedius isolates.
Isolate number dog identity PFGE type Biochem Profile Antibiogram
F1567 2 S. intermedius A 6716113 61000
F1568 1a S. intermedius B 6716153 61000
F1569 1b S. intermedius B 6716153 61000
F1570 3 S. intermedius A 6716153 61000
F1571 6 S. intermedius A 6716153 61200
F1572 7 S. intermedius A 6716153 61200
Isolates from dogs 2, 1b and 3 were from shunt – associated tissue. Those from dogs 1a, 6 and 7 were from the inside of the shunt tubing (1a and 
1b were the same dog). With reference to Fig 2, the two PFGE patterns were designated A and B to distinguish. It may be seen that the PFGE, 
biochemical and antibiogram profiles for F 1568 and F1569 (dog 1, different sites) were identical; F 1567, F 1570, F1571 and F 1572 showed slight 
differences in one or other profiles.Cerebrospinal Fluid Research 2008, 5:17 http://www.cerebrospinalfluidresearch.com/content/5/1/17
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In spite of the inoculation of 108cfu/mL bacteria into the
ventricular catheter in four animals, in two cases the ani-
mals' own S. intermedius was also isolated, as well as from
the three uninoculated controls . S. intermedius comprises
90% of all the staphylococci isolated from canine skin
[24]. In two cases where both S. intermedius and S. epider-
midis were found in the same shunt system the S. interme-
dius  was found in the more proximal portion, and S.
epidermidis in the more distal part. Given the flow of CSF
through the shunt system this suggests the possibility of
bacterial contamination from the proximal end down to
the distal end. Comparison of the S. intermedius isolates
by three methods (Table 2) showed that the two isolates
from dog 1 (tissue from shunt track and inside of shunt
tubing) were identical but different from the isolates from
the other dogs. While the differences were only slight, all
the other isolates differed from each other in one charac-
teristic or another, suggesting that in each case the bacteria
were derived from the dog's own skin flora rather than
from cross – contamination from a single source.
S. intermedius has been isolated from a majority of healthy
canines [24] although it is rarely isolated from humans.
However, transmission to humans has occurred, some-
times resulting in clinical infection [25-27]. S. intermedius
can be confused with Staphylococcus aureus. Both are coag-
ulase positive, and produce a heat – stable nuclease, but S.
intermedius does not produce Protein A and most isolates
are clumping factor negative. Some variation can occur.
Our isolates were clumping factor positive but coagulase
negative using human plasma, and they produced a heat
– stable nuclease. Their identification was kindly con-
firmed by Professor François Vandenesch of the Univer-
sity of Lyon, France.
This paper characterizes a canine model of chronic adult
obstructive hydrocephalus. The animals survived well
with no mortality and low morbidity, providing the
opportunity for physiological studies, pathophysiological
analyses and diagnostic studies.
Conclusion
In spite of the fortuitous endogenous S. intermedius infec-
tions, which once appreciated should be avoidable in
future studies, we suggest that the model described here,
perhaps with extended post – infection monitoring, is par-
ticularly suitable for the study of the pathogenesis, pre-
vention and treatment of experimental shunt infections.
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